BioCentury
ARTICLE | Clinical News

MPI-2505 regulatory update

February 3, 2014 8:00 AM UTC

FDA accepted for review an NDA from Medac for MPI-2505 - an autopen containing subcutaneous injectable methotrexate - to treat rheumatoid arthritis, polyarticular-course juvenile RA and psoriasis. Me...